Search Within

Govindaswami Ragupathi

Formats
  1. Journal Article (90)
  2. Meeting Abstract (50)
  3. Book Section (5)
Groups
  1. Department of Medicine (145)
  2. Melanoma Disease Management Team (145)
  3. Melanoma and Immunotherapeutics Service (145)
  4. Solid Tumor Oncology Division (145)
  5. Sloan Kettering Institute Faculty (57)
  6. Molecular Pharmacology and Chemistry Program Faculty (52)

More Groups

People
  1. Philip Livingston (118)
  2. Samuel Danishefsky (44)
  3. Kenneth Lloyd (17)
  4. Maria Spassova (17)
  5. Howard Scher (16)
  6. Susan Slovin (15)

More People

Years
  1. 2025 (1)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (2)
  5. 2020 (1)
  6. 2019 (2)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (24)
  2. Cancer Research (20)
  3. Cancer Immunology, Immunotherapy (15)
  4. Clinical Cancer Research (13)
  5. Journal of the American Chemical Society (8)
  6. Vaccine (7)

More Publications

Publishers
  1. American Association for Cancer Research (57)
  2. Springer (20)
  3. American Chemical Society (14)
  4. Elsevier Inc. (9)
  5. John Wiley & Sons (4)
  6. National Academy of Sciences (4)

More Publishers

Results (145)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antibodies against tumor glycolipids and proteins, but not mucins, mediate complement-dependent cytotoxicity (CDC)
    Meeting Abstract

    Liu, N. X.; Ragupathi, G.; Cappello, S.; Musselli, C.; Lloyd, K.; Livingston, P.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Tn-cluster (c) -KLH/PAM vaccine conjugates in biochemically relapsed prostate cancer (PC): Phase I trial results
    Meeting Abstract

    Slovin, S. F.; Ragupathi, G.; Olkiewicz, K.; Tilak, J.; Terry, K.; Moore, K.; Fazzari, M.; Jakubowiak, J.; Lu, L.; Livingston, P. O.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates
    Meeting Abstract

    Kim, S. K.; Ragupathi, G.; Kagan, E.; Cappello, S.; Livingston, P. O.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Phase I trial of a synthetic Lewis(Y) - KLH conjugate vaccine on ovarian cancer patients
    Meeting Abstract

    Sabbatini, P.; Kudryashov, V.; Ragupathi, G.; Danishefsky, S.; Livingston, P.; Bornmann, W.; Spassova, M.; Zatorski, A.; Spriggs, D.; Aghajanian, C.; more...
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save
  • Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates
    Journal Article

    Kim, S. K.; Ragupathi, G.; Cappello, S.; Kagan, E.; Livingston, P. O.
    Vaccine (2000)

    Fulltext@MSK | Save
  • Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: Isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens
    Journal Article

    Wang, Z. G.; Williams, L. J.; Zhang, X. F.; Zatorski, A.; Kudryashov, V.; Ragupathi, G.; Spassova, M.; Bornmann, W.; Slovin, S. F.; Scher, H. I.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2000)

    Fulltext@MSK | Save
  • Autoimmune and antitumor consequences of antibodies against antigens shared by normal and malignant tissues
    Journal Article

    Livingston, P. O.; Ragupathi, G.; Musselli, C.
    Journal of Clinical Immunology (2000)

    Fulltext@MSK | Save
  • Immunization of ovarian cancer patients with a synthetic Lewis(y)- protein conjugate vaccine: A phase 1 trial
    Journal Article

    Sabbatini, P. J.; Kudryashov, V.; Ragupathi, G.; Danishefsky, S. J.; Livingston, P. O.; Bornmann, W.; Spassova, M.; Zatorski, A.; Spriggs, D.; Aghajanian, C.; more...
    International Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21
    Journal Article

    Ragupathi, G.; Meyers, M.; Adluri, S.; Howard, L.; Musselli, C.; Livingston, P. O.
    International Journal of Cancer (2000)

    Fulltext@MSK | Save
  • Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21
    Journal Article

    Gilewski, T.; Adluri, S.; Ragupathi, G.; Zhang, S.; Yao, T. J.; Panageas, K.; Moynahan, M.; Houghton, A.; Norton, L.; Livingston, P. O.
    Clinical Cancer Research (2000)

    Fulltext@MSK | Save